Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
MIMEDX GROUP, INC.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-76.7% vs price
Base Case (Median)
-23.1% vs price
Bull Case (75th pct.)
25.3% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $5.04 | 9.7% | High (40%) |
| PE Comparable | $0.90 | -80.4% | Medium (25%) |
| Growth Trajectory DCF | $0.78 | -83.0% | Medium (20%) |
| Graham Number | $1.25 | -72.8% | Medium (40%) |
| EV/EBITDA | $6.58 | 43.4% | Medium (20%) |
| EV/FCF | $6.46 | 40.8% | Medium (20%) |
| Earnings Power Value | $3.53 | -23.1% | Medium (50%) |
Based on 7 out of 7 methods, MDXG appears fairly valued at the current price of $4.59. The base case fair value of $3.53 implies 23.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.